Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P190008/S045

IN.PACT AV Paclitaxel-coated PTA Balloon Catheter

Medtronic Vascular, Inc. · Decision date Sep 16, 2025

FDA DECISIONP190008/S045

What did the FDA decide?

FDA records P190008/S045 as a supplement to PMA P190008, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 16, 2025.

FDA approval order statement

an update to the laser-etching software for etching luer components
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 16, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P190008/S045
Regulatory pathway
PMA supplement
Product code
PRC
Decision code
OK30
Decision date
Sep 16, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Drug-coated peripheral transluminal angioplasty catheter.

Product code
PRC
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P190008/S044 · Related supplement

    IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter

  2. P190008/S045 received

    Application receipt date recorded by FDA.

  3. P190008/S045 · FDA decision

    30-Day Notice

  4. P190008/S038 · Related supplement

    IN.PACT AV Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter

  5. P190008/S046 · Related supplement

    IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter

  6. P190008/S047 · Related supplement

    IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter

  7. P190008/S048 · Related supplement

    IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter

  8. P190008/S049 · Related supplement

    IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter

Timeline entries are records held by MedtechLedger for P190008. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P190008

Explore the linked device profile

Other records with product code PRC

Product / regulatory recordCompanyPathwayDecision dateSource
LutonixPMA supplementJul 9, 2026FDA
LutonixPMA supplementSep 4, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3576 Unocal Pl., Santa Rosa, CA, 95403

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records